Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Blood products recombinant coagulation factors

Cryoprecipitate is a blood product that is manufactured from fresh frozen plasma. It contains a subset of coagulation factors fibrinogen (minimum of 150mg/unit), factor VIII (minimum 80IU/unit), von Willebrand factor (VWF) and factor XIII. With the production of recombinant and purified factor concentrates, the classical indications of haemophilia A and von Willebrand disease are no longer appropriate. Currently, cryoprecipitate is used to treat hypofibrinogemia. [Pg.486]

Gene cloning could potentially provide contaminant-free blood products of high purity. A coagulation factor, Factor VIII, is required by certain haemophiliacs. The risk of hepatitis and acquired immune deficiency syndrome (AIDS) due to the unintentional collection of blood from virus carriers identified this factor as a candidate for production by DNA recombinant techniques. [Pg.230]

See other pages where Blood products recombinant coagulation factors is mentioned: [Pg.329]    [Pg.398]    [Pg.185]    [Pg.175]    [Pg.127]    [Pg.771]    [Pg.175]    [Pg.781]    [Pg.189]    [Pg.395]    [Pg.244]    [Pg.164]    [Pg.259]    [Pg.231]   
See also in sourсe #XX -- [ Pg.676 ]



SEARCH



Blood coagulation

Blood coagulation factors

Blood-Coagulating Factors

Coagulation factors

Coagulation factors recombinant

Recombinant production

Recombination products

© 2024 chempedia.info